Product Information
ADZENYS XR-ODT 9.4 MG TABLET is a brand product labeled by Neos Therapeutics Brands, LLC, priced at $19.1952 per EA under NDC 70165001530. Its NADAC has been published 501 times since Jan 18, 2017.
FDA first approved this application on Jan 27, 2016. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.
Strength
9.4 mg/1
Manufacturer
Neos Therapeutics Brands, LLCNDC
70165001530
Classification
Brand
Dosage Form
TABLET, ORALLY DISINTEGRATING
Route
ORAL
Effective Date
8/19/2026
Active Ingredients
AMPHETAMINEApproval Type
New Drug (NDA)
FDA Application
NDA204326FDA Approved
1/27/2016
TE Code
AB
On Market Since
2/16/2016
Pharmacological Classes
Price Statistics
The NADAC for ADZENYS XR-ODT 9.4 MG TABLET has been published 501 times since Jan 18, 2017, and over the history we have for it it has risen 103.1%. The table below summarizes its recorded NADAC range and movement.
| Current price | $19.1952 per EA |
|---|---|
| All-time high | $19.3698 (Jan 14, 2026) |
| All-time low | $9.3059 (Sep 20, 2017) |
| 52-week high | $19.3698 |
| 52-week low | $19.1699 |
| Median price | $13.9275 |
| Average price | $13.6602 |
| Largest weekly change | +14.9% (Aug 13, 2025) |
| Weeks tracked | 501 |
| Tracking since | Jan 18, 2017 |
Generic Alternatives
The matcher finds 1 manufacturer offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). Switching to the cheapest would cut per-unit acquisition cost by roughly 15% at current NADAC. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Frequently asked questions
What is the NADAC price of ADZENYS XR-ODT 9.4 MG TABLET?
The current National Average Drug Acquisition Cost (NADAC) for ADZENYS XR-ODT 9.4 MG TABLET, manufactured by Neos Therapeutics Brands, LLC, is $19.1952 per EA (NDC 70165001530), effective Aug 19, 2026.
How has the price of ADZENYS XR-ODT 9.4 MG TABLET changed over time?
Over the history we have for it, the NADAC for ADZENYS XR-ODT 9.4 MG TABLET has risen 103.1%. It has been tracked across 501 weekly CMS publications since Jan 18, 2017.
What are the highest and lowest recorded NADAC prices for ADZENYS XR-ODT 9.4 MG TABLET?
Since Jan 18, 2017, the NADAC for ADZENYS XR-ODT 9.4 MG TABLET has ranged from a low of $9.3059 (Sep 20, 2017) to a high of $19.3698 (Jan 14, 2026), with a median of $13.9275 per EA.
Are there cheaper alternatives to ADZENYS XR-ODT 9.4 MG TABLET?
Yes. 1 manufacturer publishes a NADAC-priced product with the same active ingredient and strength in a comparable dosage form. The lowest-priced option, AMPHETAMINE ER 9.4 MG ODT, is $16.2264 per EA — about 15% below ADZENYS XR-ODT 9.4 MG TABLET.
Who manufactures ADZENYS XR-ODT 9.4 MG TABLET?
ADZENYS XR-ODT 9.4 MG TABLET (NDC 70165001530) is labeled by Neos Therapeutics Brands, LLC, and CMS classifies it as a brand product.